Cargando…

Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells

Motivation: As ‘omics’ biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation...

Descripción completa

Detalles Bibliográficos
Autores principales: Schissler, A. Grant, Li, Qike, Chen, James L., Kenost, Colleen, Achour, Ikbel, Billheimer, D. Dean, Li, Haiquan, Piegorsch, Walter W., Lussier, Yves A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908332/
https://www.ncbi.nlm.nih.gov/pubmed/27307648
http://dx.doi.org/10.1093/bioinformatics/btw248
_version_ 1782437661191962624
author Schissler, A. Grant
Li, Qike
Chen, James L.
Kenost, Colleen
Achour, Ikbel
Billheimer, D. Dean
Li, Haiquan
Piegorsch, Walter W.
Lussier, Yves A.
author_facet Schissler, A. Grant
Li, Qike
Chen, James L.
Kenost, Colleen
Achour, Ikbel
Billheimer, D. Dean
Li, Haiquan
Piegorsch, Walter W.
Lussier, Yves A.
author_sort Schissler, A. Grant
collection PubMed
description Motivation: As ‘omics’ biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples. Results: In response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcriptome dynamics through the analysis of aggregated cell–cell statistical distances within biomolecular pathways. Cell–cell statistical distances are calculated from pathway mRNA fold changes between two cells. Within an elaborate case study of circulating tumor cells derived from prostate cancer patients, we develop analytic methods of aggregated distances to identify five differentially expressed pathways associated to therapeutic resistance. Our aggregation analyses perform comparably with Gene Set Enrichment Analysis and better than differentially expressed genes followed by gene set enrichment. However, these methods were not designed to inform on differential pathway expression for a single cell. As such, our framework culminates with the novel aggregation method, cell-centric statistics (CCS). CCS quantifies the effect size and significance of differentially expressed pathways for a single cell of interest. Improved rose plots of differentially expressed pathways in each cell highlight the utility of CCS for therapeutic decision-making. Availability and implementation: http://www.lussierlab.org/publications/CCS/ Contact: yves@email.arizona.edu or piegorsch@math.arizona.edu Supplementary information: Supplementary data are available at Bioinformatics online.
format Online
Article
Text
id pubmed-4908332
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-49083322016-06-17 Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells Schissler, A. Grant Li, Qike Chen, James L. Kenost, Colleen Achour, Ikbel Billheimer, D. Dean Li, Haiquan Piegorsch, Walter W. Lussier, Yves A. Bioinformatics Ismb 2016 Proceedings July 8 to July 12, 2016, Orlando, Florida Motivation: As ‘omics’ biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples. Results: In response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcriptome dynamics through the analysis of aggregated cell–cell statistical distances within biomolecular pathways. Cell–cell statistical distances are calculated from pathway mRNA fold changes between two cells. Within an elaborate case study of circulating tumor cells derived from prostate cancer patients, we develop analytic methods of aggregated distances to identify five differentially expressed pathways associated to therapeutic resistance. Our aggregation analyses perform comparably with Gene Set Enrichment Analysis and better than differentially expressed genes followed by gene set enrichment. However, these methods were not designed to inform on differential pathway expression for a single cell. As such, our framework culminates with the novel aggregation method, cell-centric statistics (CCS). CCS quantifies the effect size and significance of differentially expressed pathways for a single cell of interest. Improved rose plots of differentially expressed pathways in each cell highlight the utility of CCS for therapeutic decision-making. Availability and implementation: http://www.lussierlab.org/publications/CCS/ Contact: yves@email.arizona.edu or piegorsch@math.arizona.edu Supplementary information: Supplementary data are available at Bioinformatics online. Oxford University Press 2016-06-15 2016-06-11 /pmc/articles/PMC4908332/ /pubmed/27307648 http://dx.doi.org/10.1093/bioinformatics/btw248 Text en © The Author 2016. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Ismb 2016 Proceedings July 8 to July 12, 2016, Orlando, Florida
Schissler, A. Grant
Li, Qike
Chen, James L.
Kenost, Colleen
Achour, Ikbel
Billheimer, D. Dean
Li, Haiquan
Piegorsch, Walter W.
Lussier, Yves A.
Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
title Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
title_full Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
title_fullStr Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
title_full_unstemmed Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
title_short Analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
title_sort analysis of aggregated cell–cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells
topic Ismb 2016 Proceedings July 8 to July 12, 2016, Orlando, Florida
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908332/
https://www.ncbi.nlm.nih.gov/pubmed/27307648
http://dx.doi.org/10.1093/bioinformatics/btw248
work_keys_str_mv AT schissleragrant analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT liqike analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT chenjamesl analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT kenostcolleen analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT achourikbel analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT billheimerddean analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT lihaiquan analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT piegorschwalterw analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells
AT lussieryvesa analysisofaggregatedcellcellstatisticaldistanceswithinpathwaysunveilstherapeuticresistancemechanismsincirculatingtumorcells